Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release – Zacks.com

Signal Genetics, Inc. (MGEN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 11. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus Estimate

This company is expected to post quarterly loss of $0.25 per share in its upcoming report, which represents a year-over-year change of +24.2%.

Revenues are expected to be $0.97 million, up 102.1% from the year-ago quarter.

Estimate Revisions Trend

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings Whisper

Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Signal Genetics, Inc.

For Signal Genetics, Inc.The Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Signal Genetics, Inc. Will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?

While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Signal Genetics, Inc. Would post a loss of $0.30 per share when it actually produced a loss of $0.36, delivering a surprise of -20%.

Over the last four quarters, the company has beaten consensus EPS estimates just once.

Bottom Line

An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Signal Genetics, Inc. Doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

See original here:
Signal Genetics, Inc. (MGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Zacks.com

When Tough Weather Hits Crops, Modern Genetics Helps Them Perform – Hoosier Ag Today

Amazing-modern-genetics

Will the 2020 crop season shape up like last year? It would be quite a stretch to think the elements could stoop to that level a second year in a row.

Ive been in the industry 35 years and my dad is 86, says John Kermicle, Brand Manager for AgriGold. He kept comparing last year to other years and finally said, John, there hasnt been any other year like 2019. So, it was the worst.

Kermicle was in Texas last week at the companys Commodity Classic trade show booth. He told HAT the advances in seed and seed treatments continue to benefit farmers in good conditions and bad.

In general, corn yields were pretty good again, he said. Some areas were off, but truly todays genetics with the treatments that we have today, its not like the 1980s or early 2000s. They can handle an amazing amount of weather and still do pretty well.

In presentations at the AgriGold booth, Kermicle touted their customers success in the most recent corn yield contest. The contest, he says, is another important tool for corn growers.

We want to help growers grow more corn. Thats why were in business. So, the contest really helps growers think outside the box, and then how can we take these learnings and apply it across whole farm operations? Thats kind of our approach.

He says there are several new products in the 2020 lineup.

We have a really strong research program and the first time we see some of our products are as conventionals. Were introducing eight new conventionals that will then have traits a year of two after that.

Learn more at http://agrigold.com/.

Read more from the original source:
When Tough Weather Hits Crops, Modern Genetics Helps Them Perform - Hoosier Ag Today

Sarah Elsea, PhD, FACMG Is Elected to the Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine – BioSpace

BETHESDA, Md., March 4, 2020 /PRNewswire/ --Sarah H. Elsea, PhD, FACMG, professor of molecular and human genetics at Baylor College of Medicine and senior director of biochemical genetics at Baylor Genetics, has been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine.The ACMG Foundationis a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice. The board members are active participants, serving as advocates for the Foundation and for advancing its policies and programs. Dr. Elsea was elected to a two-year term starting immediately.

"It is our pleasure to welcome Dr. Sarah Elsea to the ACMG Foundation Board of Directors. Dr. Elsea's experience in medical genetics and commitment to the mission of the College will add greatly to our ability to support clinical and educational activities on behalf of our members and the public," said ACMG Foundation President Bruce R. Korf, MD, PhD, FACMG.

Dr. Elsea received a Bachelor of Science in Chemistry with a minor in biology from Missouri State University and a PhD in biochemistry from Vanderbilt University. She completed postdoctoral fellowships in molecular and biochemical genetics at Baylor College of Medicine and is board certified by the American Board of Medical Genetics and Genomics.She held faculty appointments at Michigan State University and the Medical College of Virginia at Virginia Commonwealth University prior to returning to Baylor College of Medicine in 2013. Her research is focused on the discovery, pathomechanisms, diagnosis and treatment of rare and complex disease, particularly neurodevelopmental and metabolic disorders that involve sleep disturbance, behavioral phenotypes, obesity and cancer. While most of the work in Dr. Elsea's lab has a molecular basis, her work with children and families living with Smith-Magenis syndrome and other neurodevelopmental disorders has focused several studies toward the family, sibling and caregiver experience for those caring for and living with individuals with complex neurodevelopmental conditions. Her primary goals have focused toward supporting education and research to develop appropriate interventions to improve the health and quality of life of persons with neurodevelopmental and metabolic disorders using an integrated approach to education, outreach and mentoring. Dr. Elsea works collaboratively with support groups to develop relevant, targeted research to inform and improve upon quality of life for individuals affected by genetic conditions. Dr. Elsea serves on the board of directors of the American Board of Medical Genetics and Genomics and is chair of the Parents and Researchers Interested in Smith-Magenis Syndrome (PRISMS) Professional Advisory Board.

About being elected to the ACMG Foundation Board of Directors, Dr. Elsea said, "As we focus toward defining targeted treatments for both rare and common disease, we have an increasing need to translate genetics in healthcare.The mission of the Foundation to support and foster the training and education of medical geneticists and to enhance community education and awareness of genetics and genomics is at the heart of my work. I am both honored and delighted for the opportunity to support the ACMG Foundation Board of Directors, and I look forward to working with the Foundation to advance these goals."

A complete roster of the ACMG Foundation board can be found at http://www.acmgfoundation.org.

About the ACMG Foundation for Genetic and Genomic Medicine

The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation supports the American College of Medical Genetics and Genomics (ACMG) mission to "translate genes into health." Through its work, the ACMG Foundation fosters charitable giving, promotes training opportunities to attract future medical geneticists and genetic counselors to the field, shares information about medical genetics and genomics, and sponsors important research. To learn more and support the ACMG Foundation mission to create "Better Health through Genetics" visit acmgfoundation.org.

Kathy Moran, MBAkmoran@acmg.net

View original content to download multimedia:http://www.prnewswire.com/news-releases/sarah-elsea-phd-facmg-is-elected-to-the-board-of-directors-of-the-acmg-foundation-for-genetic-and-genomic-medicine-301015856.html

SOURCE American College of Medical Genetics and Genomics

Go here to see the original:
Sarah Elsea, PhD, FACMG Is Elected to the Board of Directors of the ACMG Foundation for Genetic and Genomic Medicine - BioSpace

Demand for Well-bred Animals With Desirable Genetic Traits to Drive Animal Genetics Market: Transparency Market Research – PRNewswire

ALBANY, New York, March 4, 2020 /PRNewswire/ -- Owing to multiple factors such as adoption of advanced technologies, high demand for well-bred animals with desirable genetic traits (livestock and poultry), and increase in disposable income is helping the global animal genetics marketchart a Compound Annual Growth Rate of 6.0 % from 2018 to 2026. As a result of this robust growth rate, market would be reach a valuation of USD 8.0 bn by the end of the forecast period.

Transparency Market Research states, "One of the most significant trends that will lead to a higher market growth over the forecast period is increase in ownership of companion animals. Besides, with food safety and quality gaining prominence, the live animal segment will show significant growth from 2018 to 2026."

Key Findings of the Animal Genetics Market Study

Explore 157 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on Animal Genetics market by Product Type - Live Animals (Bovine, Porcine, Poultry, Canine, and Piscine), Genetic Material (Semen, Embryo), Genetic Testing, Read Details TOC of the Report - https://www.transparencymarketresearch.com/report-toc/18995

Animal Genetics Market: Key Driving Factors

The animal genetics market is set to witness sturdy growth over the forecast period owing to a plethora of trends and growth drivers. As per Transparency Market Research, some of the crucial factors are high level of consumption of meat and poultry products, increase in purchasing power of people, need to plug supply gaps in terms of food, and growing demand for stronger animals, well-bred and with desirable genetic traits. An overview of growth factors is provided below:

Request PDF Brochure of Animal Genetics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18995

Key Impediments for Animal Genetics Market Players

Despite charting a steady growth curve over the forecast period, the global animal genetics market would not be free from restraints. As per Transparency Market Research, one of the major restraints that will limit growth in the global animal genetics market is the regulatory environment which is strict in terms of animal genetic engineering. Besides, a notable dearth of skilled professionals in the market is also a limiting factor in the global animal genetics market. Additionally, it is worth noting that animal testing is expensive.

Animal Genetics Market: Region-wise Analysis

Analyze Animal Genetics market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sampleof the study,

Competition Landscape

Research and Development (R&D) forms the core of global animal genetics market and is thus a major determinant of the size of market share a player holds. Besides, players also forge partnerships in order to tap into uncharted territories in order to bring a larger consumer base into the fold. It is pertinent to note here that technology also holds a prominent place in the market.

Transparency Market Research has profiled key players such as Genus plc, CRV Holding B.V., Neogen Corporation Zoetis, Inc., Groupe Grimaud, Topigs Norsvin, VetGen, Animal Genetics Inc., and Hendrix Genetics BV, in its market report. The global animal genetics market has a decent number of players operating the market landscape.

Transparency Market Research has segmented the Animal Genetics market report based on product type, geography and forecast.

Product Type:

Explore Transparency Market Research's award-winning coverage of the Global Healthcare Industry:

Thyroid Function Test Market: The global thyroid function test market was valued at approximately US$ 1.3 Bn in 2018. It is anticipated to exceed a value of US$ 2.4 Bn by 2027, expanding at a CAGR of more than 5% from 2019 to 2027. The global market is driven by an increase in the incidence of thyroid disease, rise in geriatric population, increase in obese, diabetic, and cardiovascular patients, and increase in disease awareness programs in developing regions.

DNA Test Kits Market: The global DNA test kits market is driven by increase in the number of direct to consumer genetic testing companies offering DNA tests for ancestry and health & fitness, rise in focus on health risk & preventive care, and increase in demand for ancestry DNA testing services across the globe.

Audiological Devices Market: The global audiological devices market was valued at about US$ 8.7 Bn in 2017 and is expected to reach a value of US$ 13.4 Bn by 2026, expanding at a compound annual growth rate (CAGR) of over 5.0% from 2018 to 2026. The global market is witnessing expansion at a relatively higher growth rate owing to the increasing geriatric population, adoption of audiological devices due to rising number of cases of hearing loss, and surge in research and development in both developed and developing markets.

Laser Capture Microdissection Market: Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key tohelp enterprises reach right decision."

Contact

Transparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected]

Website: http://www.transparencymarketresearch.com

SOURCE Transparency Market Research

Continued here:
Demand for Well-bred Animals With Desirable Genetic Traits to Drive Animal Genetics Market: Transparency Market Research - PRNewswire

Helmets protect athletes’ skulls. Will the NFL use neuroscience to protect their brains? – Massive Science

As a spectator, its easy to forget the long term consequences of 300 pound humans crashing intoeach other at over 20 miles per hour. But this is the reality of American football. During play, the brain is one of the most susceptible parts of the body and thelong-termdanger may remain hidden until years after retirement.

New safety rules and improved helmets prevent injuries such as skull fractures. But no amount of training or equipment is yet known to prevent concussions, internal brain injuries caused when the brain shakes back and forth, or chronic traumatic encephalopathy (CTE), the neurodegenerative disease that results from accumulated hits to the head. The best thing we can do is stop playing these types of sports. The second best option is to mitigate the risks.

The NFL is plagued with controversy over the league's relationship with head injuries. Traditional helmets are designed to prevent skull fractures. However, concussions are not just blunt force trauma, but results of rotational forces exerted when the head snaps back and forth.

Symptoms of CTE don't appear until years or decades after chronic impacts

Wikimedia Commons

If the NFL wants to get serious about concussion prevention, as many believe they morally have a responsibility to do, independent neuroscience has to have a leading role in how helmets are designed.While the NFL denies bias in how they use science, it is impossible to deny that they have a large financial interest in the results, and this has led to questionable measures on head protection. From 1994 to 2009, the NFL actually employed their own research committee. But the committee was overhauled in 2009 after criticismfrom Congress for their continued denial of the link between football and brain disease.

And then there are equipment companies like Riddell, which was sued by thousands of former NFL players in 2013 for falsely claiming that players using their Revolution helmet were 31 percent less likely to get a concussion. Riddell based their marketing on a study of their new helmet by scientists at the University of Pittsburgh Medical Center. Even when the authors of the paper informed Riddell that their interpretation of their results was wrong (the actual reduction was closer to 2 percent), Riddell failed to alter the original claim.

Sciences approach for the modern American football helmet

If youve ever been a passenger in a car that suddenly slams on its breaks, you know a little of what it's like to be tackled. You probably fall forward, kept in your seat by your seat belt. The car stopped, but you were still rapidly accelerating. You experienced a linear force.Measurements on a college player showed the average acceleration of 10 hits he took during a single game. Each hit was roughly equivalent to what you would feel if you crashed a car into a wall going about 30 miles per hour.

Players' brains are very vulnerable in such a high-impact sport

Photo by Robina Weermeijer on Unsplash

Understanding of concussions and CTE has evolved significantly over the past few years and helmet designs are now just starting to catch up with the research. For example, scientists once thought that a concussion only bruised the outer grey matter surface of the brain.New research published over the past five years demonstrates that the brain doesnt bruise, but does experience rotational forces and damage extending to white matter, deep tissue in the brain, as the fibers in white matter pull and twist upon impact.

Designing a better helmet is about being creative about reducing the rapid deceleration of the brain upon impact. In 2013, the start up company VICIS set out to create a helmet based on this current medical knowledge, with neurosurgeons, concussion specialists, and former NFL team physicians as advisers. Their approach focused on rotational forces on the brain instead of just linear ones.

Thanks to the more than $85 million raised, $1.1 million from the NFL, they launched the ZERO1 helmet in 2016. This product has a reflex layer'' inside the shell composed of dozens of separate columns of padding, which bend, compress, and move in response to force in every direction, whether it's linear or rotational. The helmet also has a deformable'' outer shell that morphs its shape when hit, acting like a car bumper to absorb the blow. Since acceleration is speed divided by time, you can reduce acceleration by either decreasing speed or prolonging the time of the impact. The idea behind the car bumper properties of ZERO1 is that it increases thetime of impact.

In 2018, 120 professional and college teams wore the ZERO1. Performance testing suggests that this collaborative approach between scientists and sports was working. The ZERO1 football helmet was ranked #1 in ability to reduce force to the head in the NFLs and NFL Player Association helmet laboratory performance testing from 2017-2019, every year it has been available.

While this innovative helmet design washailed by neuroscientists, players, and sports leagues alike, VICIS did not survive competition with Schutt and Riddell, the two dominant companies in the helmet industry. In late 2019, VICIS announced it was out of money.

Other scientists are taking up the challenge to build a better helmet. David Camarillo is not just an Assistant Professorat Stanford University, he is also a former college football tight end. In 2013,his research labdeveloped computerized mouth guards to help accurately chart head acceleration data upon head impacts.

Former NFL player Junior Seau died at age 43. The NIH concluded that he suffered from CTE

Wikimedia Commons

While most helmets use solids to absorb energy, like foam or the columns in the VICIS ZERO1, the Camarillo lab'sapproach introduces liquid into thehelmetwith the idea that liquids can absorb more energy than solids. Camarillo compares the design to a hydraulic shock absorber." The team used computer simulations of an NFL impact test and compared the liquid approach with four other helmets with different energy absorption technologies. Results from his study suggest that the helmet reduces the average brain tissue strain upon impact by about 25 percent and could reduce concussions by at least 75 percent. However, as these results are still based entirely on computer simulations, the safety and logistics of building an actual helmet are still in research stages.

A concussion is not the same as CTE

While these new helmets are intended to prevent concussions, singular events caused by one hit, they may still be insufficient to protect against CTE. CTE is a neurodegenerative disease resulting from cumulative hits, whether they are concussive or not, that occur many times over many years. CTE is nearly impossible to study as symptoms almost never occur until many years or decades after repeated head trauma and positive diagnosis is only possible through an autopsy after death.

Ann McKee is a neuropathologist and expert in neurodegenerative diseases. She also directs Boston Universitys CTE Center. Her 2017 paper became famous when it suggested that 99 percent of former NFL players showed pathological evidence of CTE based on data collected from former players whose brains had been donated to Boston brain banks. The paper was scrutinized on the grounds that brains donated for CTE diagnosis may be biased towards CTE presence (i.e. family members saw the signs while the donor was alive). Her 2019 article enhances the correlation by being the first paper to include a non-football playing control group.

Experts are still trying to understand how head injuries, concussions, and other factors change the brain to cause CTE.Some scientists, such as the VICIS team and the Camarillo lab, believe that reducing the fierceness of the hardest hits that result in isolated concussions through more effective helmets will reduce the number and severity of CTE cases.

In the past decade, the NFL has spent over$200 million on concussion research, with multi-million dollar contributions in 2016 and 2018. However, at least some of that research has been overshadowed by what seems on the surface like a practice of funding labs associated with the NFL while withholding funds from labs that are critical of the organization. Players' lives are at stake and it is beyond time that the multi-billion dollar organizations that run this sport start putting players over profits. New helmet designs may be exciting parts of the solution, but only if the goal remains focused on sparing participants a lifetime of brain damage. In mid-November 2019, the NFL announced a $2 million grant competition to create a new top performing helmet. Let's hope that it will go to unbiased researchers with good intentions.

More:
Helmets protect athletes' skulls. Will the NFL use neuroscience to protect their brains? - Massive Science

What Neuroscience Can Tell Us About Nutrition – Thrive Global

Extreme obesity can knock eight years off your life, according to one Canadian study. But even being overweight has a clear impact on how we age. One study found that obese people had substantially less white matter in their brains than leaner people. While our brains naturally shrink with age, the brains of the obese people were found to have a comparable white matter volume to a lean person 10 years their senior. The impact on cognitive function is not known, but its unlikely to be good.

Obesity is the main cause of type 2 diabetes, which is most prevalent in older people. The number of Brits with type 2 diabetes has doubled in 20 years and it now accounts for almost 9 per cent of the annual NHS budget. A third of Americans over 65 now have type 2 diabetes. The consequences can be really nasty: blurred vision, sores which wont heal, even toe, foot and leg amputations.

Type 2 diabetes develops when our bodies consume so many carbohydrates that the pancreas ceases to release the right amounts of the hormone insulin into the blood, to regulate the glucose that gives us energy. Our systems are overwhelmed and they fail.

People who head into their sixties obese are storing up real trouble in Extra Time. Doctors are wary of interfering, because they feel that what we eat is a lifestyle choice. Personally, Im not so sure how much of a choice it is. Public health agencies have spent decades exhorting people to lose weight with almost no effect. I have become convinced that one reason we find it so hard to lose weight is that junk foodespecially sugaris addictive.

When I served on the board of the Care Quality Commission, the national regulator for hospitals, the scourge of obesity was every-where. Hospitals were having to reinforce beds for super-sized patients. Doctors were refusing knee replacements to people who were so overweight they feared the replacements would buckle under the strain. Some of those people became less active because their joints hurt and so gained even more weight. It was a terrible vicious cycle.

Around the same time I watched a talk by the American paediatric endocrinologist Professor Robert Lustig. He argues that sugar is the main cause of obesity, because sugar is as addictive as nicotine and switches on the same hormonal pathways which reward behaviour. Low blood sugar affects mood, concentration and the ability to inhibit impulse. Eating or drinking something sugary reverses the effect, but if the pattern is repeated for long enough, it results in insulin resistance, type 2 diabetes, heart disease and obesity. Professor Lustig believes that it is not possible for most people to quit through willpower because that has been eroded by the cycle of craving.

My mothers switch from nicotine to sugar made Lustigs narrative especially compelling for me: she simply replaced one addiction with another. And it chimed with my own experience. Battling exhaustion after my third child, and sitting opposite a fellow columnist who practically mainlined Coca-Cola, I fell into the habit of needing a Coke and chocolate bar before every deadline. Since I was filing copy almost everyday, as a Times leader writer, my consumption of sugar was considerable. And pretty soon the chocolate bar was no longer a single small, elegant Green & Blacks, but a string of Yorkie bars.

This kind of mindless eating has been brought to life, hilariously and poignantly, in experiments by Brian Wansink of Cornell University. In one, he gave stale popcorn to two groups of cinema-goers. One group got big buckets, the other got giant buckets so large that researchers assumed no one would finish them. When the movie ended, the people with giant buckets had scoured them clean theyd consumed 50 per cent more popcorn than the others. When told this, most were astonished.

For decades, we were warned off saturated fat. A profitable industry grew up selling low-fat processed foods. But these are a con. To make them tasty, manufacturers stuff them with carbohydrates and sugar. These create spikes in blood-sugar levels, which lead to cravings when blood sugar falls, along with the brains chemical messenger, dopamine. Dopamine gives pleasure, but also regulates our self-control. So Big Food offering low-fat cakes is the equivalent of Big Tobacco offering low-tar cigarettes: they make us feel better about ourselves, while keeping us hooked.

I hope that doesnt sound hysterical. In 2015, there was a mortifying moment when I was called a health fascist by one of the prime ministers other advisers. We had just come out of his office in Downing Street, where I had been arguing that we should tax sugary drinks. I was taken aback to hear myself described as fascist. But I believed we could no longer rely on exhortation to stem the obesity epidemicwe needed manufacturers to change their ingredients.

In 2016, the UK government announced that it would levy a tax on sugary drinks to tackle obesity. By the time the levy came into force two years later, most brands had already done what we had hoped they would: reformulate to avoid the tax, thus withdrawing substantial amounts of sugar from the supermarket shelves. While a few customers have complained about taste and Coca-Cola has refused to dilute its legendary Classic many are switching to low-sugar products. This suggests that relatively small signals can change markets.

Reformulating food is much more complicated for the obvious reason that processed foods contain far more ingredients than drinks (if you remove all the sugar from a cake, it will simply collapse and look like a souffl). But the UK government has already had some success in working with manufacturers to remove salt from processed foods. The same could be done for sugarwith the right combination of goodwill and political drive.

The assault on cigarettes was only partially about taxing and making them more expensive. It also involved health warnings on packets and restrictions on advertising. We need clear, unequivocal health warning on processed food and drink in a universal language, not complex labels in small print that few of us can make sense ofespecially when were rushing down a supermarket aisle, vulnerable to pester power. One doctor recently told me that the government should be focusing on parents and grandparents, not child obesity. Unless the parents and grandparents lose weight, she said, weve got no chance with the children.

Parents and grandparents may not trust government, or the media, to tell them what to do. But they do trust doctors.

Follow ushereand subscribeherefor all the latest news on how you can keep Thriving.

Stay up to date or catch-up on all our podcasts with Arianna Huffingtonhere.

Read the original post:
What Neuroscience Can Tell Us About Nutrition - Thrive Global

Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates – Yahoo Finance

Award Winning Agency Will Help Democratize Neuroscience for Companies Worldwide

Immersion Neuroscience, the worlds most advanced predictive software company unlocking neuroscience to measure what people love, has selected Bob Gold & Associates, a nationally recognized boutique public relations and marketing agency, as its public relations agency of record to help launch its new cloud-based audience prediction platform. The Immersion platform helps companies identify, quantify and predict what live or taped events, training, and entertainment motivate audiences to action so that companies can significantly improve their ability to connect with consumers and increase ROI.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200302005126/en/

"With more than two decades of research, weve developed an entirely new way to understand how the brain values content, and how to predict what content will drive actions with high accuracy," said Paul J. Zak, Ph.D., Founder of Immersion. "We coined the term immersion to denote a measurable neurologic state, and today, Immersion offers an easy to use and powerful tool that allows any company to analyze content and predict how audiences will respond. And it doesn't take a neuroscientist to know that Bob Gold & Associates, with their unparalleled expertise and a proven track record, is the right company to help get our story told."

Immersions proprietary solution and software is the world's most accurate way to measure the brain's unconscious emotional responses to virtually any type of content whether its video, music, live events, training, educational resources and more. Developed by distinguished research scientists, Immersions simple to use and scalable predictive SaaS platform democratizes neuroscience so that anyone can measure what people love at scale.

"Life doesnt happen inside a lab," Zak added. "Until now, companies could only measure what people in the real world said they liked not how their brains were truly valuing an experience. Immersion is able to measure what folks truly, viscerally love, anywhere, anytime and in real time."

The Immersion platform infers when the brain values an experience in real-time with a small wearable sensor that can be used anywhere. Unlike traditional neuroscience technologies that use expensive, immobile and delicate lab equipment and require highly trained professionals to collect and analyze the data, Immersion takes multiple measures of brain activity and puts them into an easy to understand 0-10 measure collected every second. Immersions clients use the platform anywhere, anytime and at scale, empowering companies to predict future behavior and market outcomes with 90% or better accuracy.

"Immersion is a revolutionary company. With their unique cloud-based solution, measuring brain activity is no longer confined to a laboratory with expensive instruments," said Bob Gold, CEO of Bob Gold & Associates. "There are billions of dollars being spent in original programming, half of which never connects with audiences. Today for every network and streaming service, hits are everything. Immersion has proven, with peer-reviewed publications and blinded studies, its ability to identify hit shows, movies, songs and so much more."

Because its built in the cloud, and not in a lab, Immersions software is portable and effortlessly scalable, enabling clients to leverage the power of neuroscience on the fly, anywhere in the world. And while other companies can take months to compile results, Immersions software provides an immediate assessment, unlocking the power of neuroscience for anyone without the need for extensive training.

In one study, for example, two measures from the platform peak immersion, and frustration were enough to predict the top-rated unscripted TV shows with 84% accuracy.

Many leading global brands are already utilizing Immersion in countless ways. This includes shaping content and business decisions by predicting hit TV shows and movies, chart-topping songs, sales bumps, TV ratings, viral content, what has the highest impact at live events, and even HR and corporate training, all by accurately identifying what is truly valued by audience members brains.

For more about Bob Gold & Associates, visit http://www.bobgoldpr.com.

To learn more about Immersion, visit http://www.getimmersion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005126/en/

Contacts

Andrew LaszacsBob Gold & Associates 310-320-2010immersion@bobgoldpr.com

Originally posted here:
Immersion Neuroscience Uncovers What Folks Really Love With a Little Help From PR Mavens at Bob Gold & Associates - Yahoo Finance

An Oregon nonprofit brings an actual brain, and brainpower to classrooms – KGW.com

PORTLAND, Ore. Getting the attention of middle school science students is a no-brainer for NW Noggin.

Students get a real hands-on experience, even holding a human brain, as the nonprofit teaches lessons in neuroscience.

We are all volunteers going into classrooms learning what kids are curious about. They ask so many questions, said NW Noggin founder Bill Griesar.

Since 2012, the nonprofit has reached 40,000 students.

On Tuesday, they visited Portlands Hosford Middle School bringing plastic models of brains, preserved sections of the brain and a real one to hold.

Its heavier than I thought it would be and squishy, recalled one student.

The program relies on graduate students from OHSU and PSU.

We bring these advanced students into classrooms so the kids can see the possibilities. Maybe they will want to follow a similar path someday, said Griesar.

NW Noggin has taken its program to other cities such as Chicago and Washington D.C.

This Saturday, March 7, theyll be at OMSIs Brain Fair.

Its really cool, one student said. This was a super fun day.

RELATED: KGW's Drew Carney explains the science behind Leap Year and Leap Day

RELATED: 'You have your life back': New brain surgery at OHSU controls debilitating tremor

Link:
An Oregon nonprofit brings an actual brain, and brainpower to classrooms - KGW.com

Alumnus builds coffee business from the ground up – The Rider News

Mark Maslanka 18 started brewing up his own coffee business while studying neuroscience at Rider. He eventually moved to Colorado where his business took off.

by Cassandra Stathis

Early in the day, it is common to hear someone say Dont talk to me till Ive had my morning coffee. It is the best part of the day for many hardworking students and employees. But what exactly is the science behind coffee?

Rider alumnus Mark Maslanka 18 is very familiar with the process behind the caffeinated beverage, as he is the proud owner of his own coffee company, named Science of Coffee.

Maslanka had a long history with coffee, even before college.

Coffee was always something that brought me relaxation, he said. And made me feel like one of the adults.

Maslankas allure to the drink was the root of inspiration behind his company.

The quality of coffee I produce today just blows me away, Maslanka said. It brings me right back to those first couple sips when I was a kid in the car with my dad.

Maslanka planned to just experiment with his favorite drink in order to perfect his recipe.

I mastered different methods from around the world in trying to produce the best tasting cup of coffee, he said.

Todd Weber, a professor of biology at Rider, had Maslanka in a past neuroscience class, and admired his work ethic when he was a student.

Mark [Maslanka] had a pragmatic approach to getting work done when it needed to be done, said Weber.

Before Maslanka left Rider, he decided to leave one last gift with his professors. It was something from the heart that he believed they would appreciate.

Mark [Maslanka] graced me with some of his coffee before he graduated. [It was] very fragrant, so much better than much of the coffee we get around here, Weber said.

Neuroscience and coffee may not seem like they have a lot in common, but Weber disagreed.

I think its very cool that Mark was able to meld his behavioral neuroscience background with a spirit of entrepreneurship to start a company around the most widely used neuroactive substance on the planet, caffeine, Weber said. Hes an ultimate scientific entrepreneur.

Maslanka had never expected his business to take off so quickly, so the success of his business came as a surprise to him.

I didnt think Id be selling coffee to people across the country, I only started this as an excuse to roast more coffee than I could drink, he said. Im just along for the ride, waiting to see where itll take me next. Everything up until this point has been purely from word of mouth besides the occasional stranger that stumbles upon my website. Thats how you know its good coffee.

Maslankas company also sells photographs of nature and wildlife that he has taken.

Its my way of showing others what untouched nature looks like deep in the wilderness. I love being able to remind people why its worth trying so hard to conserve these creatures, he said.

The Rider alumnus credits his business website with helping him get off the ground.

My site has given me a large boost in credibility in life, with a very physical example of how hard I work on things I am interested in, he said. It also got me into my current position where I am today.

Maslanka went on to discuss how coffee fits in with his work, describing the effects that different coffee beans have on the body.

One of the side projects I inherited is a coffee-omics study, investigating metabolomic differences between different coffees grown around the world, he said.

During the hours he works strictly with coffee, he is sourcing new beans in small batches from farms around the world and optimizing a roasting profile to enhance the development of the natural flavors unique to that origin.

Science of Coffee is the perfect blend of Maslankas passions, balancing neuroscience and the environment in one successful business.

Published in the 3/4/20 edition

Read the original here:
Alumnus builds coffee business from the ground up - The Rider News

The Hereditary Neuropathy Foundation’s Movement is Medicine(TM) Program Expands to Florida and Continues to Shed Light on the Impact Exercise Has on…

NEW YORK, March 3, 2020 /PRNewswire/ -- The Hereditary Neuropathy Foundation(HNF) Movement is Medicine is expanding across the US with its latest Summit announced for March 21, 2020 in Winter Park, Florida at the Center for Health and Wellbeing, which is a collaboration between the Winter Park Health Foundationand AdventHealth. The 80,000-square foot, state-of-the-art facility offers the best community health and wellness programs in Central Florida.

"The Neuromuscular Division of the AdventHealth Neuroscience Institute is overjoyed to partner with the Hereditary Neuropathy Foundation as a Center of Excellence. The HNF has established itself as an organization in which individuals with hereditary neuropathies-also known as CMT-come first. Our division echoes this goal of patients coming first. We are excited to host the Movement is Medicine program here in Orlando; this program will demonstrate not only how much exercise is necessary in hereditary neuropathies, but also how much fun exercise can be by forming new friendships and creating positive energy that can be healing in every way."

-Nivedita Jerath MD, MS Medical Director of Neuromuscular Medicine, AdventHealth

Sponsored by AdventHealth, this Movement is Medicine Summit will be free to attend and feature inspirational speakers, expert instructors and informational breakout sessions specifically curated by and for CMT patients.

Over 100 attendees are expected to participate, with children, caretakers and family members also welcome.

"HNF is thrilled to bring its groundbreaking Movement is Medicine program to Winter Park," said Allison Moore, Founder and CEO of HNF. "Our patient-centered approach to the treatment of CMT disease is aligned with the terrific work that Dr. Jerathand her team are doing at the AdventHealth Neuroscience Institute, and we couldn't be more excited to be holding our event at the Center for Health and Wellbeing.

Registerfor the Movement is Medicine Summit Orlando.

HNF is grateful for all who continue to help make these impactful Summits possible and who are making a difference in the lives of our courageous attendees.

The HNF team is also planning its annual 2-day Movement is Medicine Summit in Phoenix, AZ at Ability360 for November 13-14th, 2020.

About Hereditary Neuropathy Foundation (HNF)HNF, a non-profit 501(c) 3 organizationwhose mission is to increase awareness and accurate diagnosis of CMT and related inherited neuropathies, support patients and families with critical information to improve quality of life, and fund research that will lead to treatments and cures. HNF developed the Therapeutic Research in Accelerated Discovery (TRIAD) program, a collaborative effort with academia, government and industry, to develop treatments for CMT. Currently, TRIAD involves many groups that span the drug discovery, drug development and diagnostics continuum.

About AdventHealth's Central Florida Division:Founded in 1908 by pioneering Seventh-day Adventists who believed in whole-person health healing the body, mind and spirit AdventHealth has grown into one of the largest nonprofit hospitals in the country, caring for more than two million patient visits per year in metro Orlando alone. AdventHealth operates more than 50 hospitals and hundreds of care centers in nearly a dozen states, making it one of the largest faith-based health-care systems in the United States.

AdventHealth's Central Florida Division encompasses 20 hospitals in the seven counties in and surrounding metro Orlando: Orange, Seminole, Osceola, Polk, Lake, Volusia and Flagler. The Central Florida Division's care network also includes more than 30 Centra Care urgent-care centers; dozens of sports-rehab and imaging centers; and hundreds of physicians, ranging from primary care to a full spectrum of specialties.

AdventHealth Orlando, the division's flagship campus, serves both as a community hospital and as a major tertiary referral hospital for the region, much of the Southeast, the Caribbean and Latin America.

AdventHealth Orlando is a designated statutory teaching hospital and trains physicians from around the world on the newest technology and procedures. The system provides a wide range of health services, including many nationally and internationally recognized programs in cardiology, cancer, women's medicine, neuroscience, diabetes, orthopedics, pediatrics, transplant and advanced surgical programs.

The AdventHealth Research Institute has more than 250 investigators and more than 500 clinical trials in progress. AdventHealth Orlando is also home to the Translational Research Institute for Metabolism & Diabetes and the Nicholson Center for Surgical Advancement.

Contact: Allison MooreT: 1-855-HELPCMT (435-7268)E: allison@hnf-cure.org

View original content to download multimedia:http://www.prnewswire.com/news-releases/the-hereditary-neuropathy-foundations-movement-is-medicine-program-expands-to-florida-and-continues-to-shed-light-on-the-impact-exercise-has-on-charcot-marie-tooth-cmt-301014819.html

SOURCE Hereditary Neuropathy Foundation

See the original post:
The Hereditary Neuropathy Foundation's Movement is Medicine(TM) Program Expands to Florida and Continues to Shed Light on the Impact Exercise Has on...